From Novo Holding's purchase of Catalent to BMS's Karuna acquisition, here are 10 of the most significant M&A moments of 2024.
A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback